News

Stay updated on Vesigen innovations

Vesigen Therapeutics launches with USD 28.5 million Series A investment led by Leaps by Bayer and Morningside Ventures

Vesigen Therapeutics launches with USD 28.5 million Series A investment led by Leaps by Bayer and Morningside Ventures Vesigen Therapeutics ...

Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein

Nabhan, J., et al., Proceedings of the National Academy of Sciences (2012) ...

Plasma membrane-derived extracellular microvesicles mediate non-canonical intracellular NOTCH signaling

Wang, Q., Lu, Q., Nat Commun 8, 709 (2017) ...

ARMMs as a versatile platform for intracellular delivery of macromolecules

Wang, Q., Yu, J., Kadungure, T. et al., Nat Commun 9, 960 (2018) ...

Stay Connected